Menlo Park, CA, United States of America

Aaron Lee Berez

This inventor holds 48 USPTO granted patents and 3 published patent applications, plus 6 CIPO patents and 6 EPO patents, primarily in Vascular Stenting. Top assignees: Covidien LP, Tyco Healthcare Group LP, Conformis, Inc.. Active years: 2009-2024.

USPTO Granted Patents = 48 

% Patents Active = 64.6

 

 

Average Co-Inventor Count = 2.3

ph-index = 20

Forward Citations = 2,148(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2009 - 2018)
  • Portola Valley, CA (US) (2016 - 2024)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Vascular Stenting
Luminal Stenting
Vascular Occlusion
Flexible Occluding Device
Aneurysm Treatment
Delivery System
Deployment Method
Endovascular Procedures
Medical Devices
Interventional Techniques
Vascular Therapies
Patent Innovations
48 patents (USPTO):Explore Patents

Title: Inventor Aaron Lee Berez: Pioneering Innovations in Menlo Park

Introduction: Aaron Lee Berez is a visionary inventor based in Menlo Park, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Aaron Lee Berez holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Aaron Lee Berez has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of innovation.

Collaborations: Throughout his career, Aaron Lee Berez has collaborated with top scientists, engineers, and researchers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Aaron Lee Berez continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of technological advancement.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…